D Effort

TOKYO—Stung by foreign criticism of its scant contributions to basic research, Japan has taken steps to break down its traditionally rigid system of funding university research and to launch new ventures. Budget figures released this summer show that government support is strongest, in fact, for the least traditional of the new programs, some of which involve substantial foreign participation. The Science and Technology Agency (STA) achieved a 23 percent increase in funds for its nont

Written byAlan Engel
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

TOKYO—Stung by foreign criticism of its scant contributions to basic research, Japan has taken steps to break down its traditionally rigid system of funding university research and to launch new ventures. Budget figures released this summer show that government support is strongest, in fact, for the least traditional of the new programs, some of which involve substantial foreign participation.

The Science and Technology Agency (STA) achieved a 23 percent increase in funds for its nontraditional research programs, the seven-year-old BRATO “creative science" project and the new Frontier Research Programs. For the same period, the Ministry of Education, Science and Culture (Monbusho) reported that its budget for traditional university grants rose just 3.6 percent. And the equally conventional Research and Development Project of Basic Technology for Future Industries, run by the Ministry of International Trade and Industry (MITI), was trimmed 12 percent, leaving its future clouded.

The ERATO projects are intended ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies